Economic burden of Chagas disease in Brazil: a nationwide cost-of-illness study
Open Access
- 8 August 2025
- journal article
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 50, 101202
Abstract
No abstract availableKeywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais (RED-00192-23)
- Universidade Federal de Minas Gerais
- University of Southern Queensland
- World Heart Federation (CLCZ696D2010R)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Novartis
- Edwards Lifesciences
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
This publication has 26 references indexed in Scilit:
- WHF IASC Roadmap on Chagas DiseaseGlobal Heart, 2020
- Economic costs of Chagas disease in Colombia in 2017: A social perspectiveInternational Journal of Infectious Diseases, 2020
- The Economic Burden of Heart Conditions in BrazilArquivos Brasileiros de Cardiologia, 2018
- II Consenso Brasileiro em Doença de Chagas, 2015Epidemiologia e Serviços de Saúde, 2016
- Longitudinal study of patients with chronic Chagas cardiomyopathy in Brazil (SaMi-Trop project): a cohort profileBMJ Open, 2016
- Prevalence of Chagas disease in Brazil: A systematic review and meta-analysisActa Tropica, 2014
- Chagas' cardiomyopathy: The economic burden of an expensive and neglected diseaseInternational Journal of Cardiology, 2013
- Global economic burden of Chagas disease: a computational simulation modelThe Lancet Infectious Diseases, 2013
- Estimating the economic impact of pandemic influenza: An application of the computable general equilibrium model to the UKSocial Science & Medicine, 2011
- An Introduction to Markov Modelling for Economic EvaluationPharmacoEconomics, 1998